Grace Therapeutics
GRCE
10 hedge funds and large institutions have $4.34M invested in Grace Therapeutics in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
162% more capital invested
Capital invested by funds: $1.66M → $4.34M (+$2.68M)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
11% more funds holding
Funds holding: 9 → 10 (+1)
7.36% more ownership
Funds ownership: 6.1% → 13.46% (+7.4%)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$1.47M |
| 2 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$539K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$108K |
| 4 |
NS
NBC Securities
Birmingham,
Alabama
|
+$6 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$56K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$10.8K |
| 3 |
Morgan Stanley
New York
|
-$5.55K |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$118 |
| 5 |
IGWM
ICA Group Wealth Management
Denver,
Colorado
|
-$26 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
1
AIGH Capital Management
Baltimore,
Maryland
| $1.71M | +$1.47M | +497,359 | New |
|
2
Bank of America
Charlotte,
North Carolina
| $1.69M | – | – | – |
|
|
ACM
3
ADAR1 Capital Management
Austin,
Texas
| $745K | +$539K | +182,849 | +530% |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $126K | +$108K | +36,650 | New |
|
|
5
Royal Bank of Canada
Toronto,
Ontario, Canada
| $43K | -$56K | -19,000 | -60% |
|
6
National Bank of Canada
Montreal,
Quebec, Canada
| $7.97K | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| $6.67K | -$10.8K | -3,655 | -65% |
|
|
8
Morgan Stanley
New York
| $6.45K | -$5.55K | -1,882 | -50% |
|
|
NS
9
NBC Securities
Birmingham,
Alabama
| $1K | +$6 | +2 | New |
|
|
FDCDDQ
10
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $96 | – | – | – |
|
|
ASN
11
Advisory Services Network
Atlanta,
Georgia
| – | -$118 | -41 | Closed |
|
|
IGWM
12
ICA Group Wealth Management
Denver,
Colorado
| – | -$26 | -9 | Closed |
|
GRCE Hedge Fund Activity: Q1 2024 in Review
10 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q1 2024, worth a combined $4.34M — up 162% from $1.66M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new GRCE positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.
The largest buyer was AIGH Capital Management, opening a new position worth an estimated $1.47M. The largest seller was Royal Bank of Canada, cutting an estimated $56K.
- 10 institutional investors held Grace Therapeutics (GRCE) as of Q1 2024, up from 9 in Q4 2023.
- Funds reported $4.34M of Grace Therapeutics stock for Q1 2024, up 162% quarter-over-quarter.
- 3 funds opened new Grace Therapeutics positions in Q1 2024 and 2 closed out, a net change of +1 holder.
- The largest Grace Therapeutics buyer in Q1 2024 was AIGH Capital Management, an estimated $1.47M added.
- The largest Grace Therapeutics seller in Q1 2024 was Royal Bank of Canada, an estimated $56K sold.
Based on aggregated 13F filings for Q1 2024.